News items related to:
-
Thailand, Ukraine, and Uzbekistan Fight Delamanid Monopolies in an Effort to Expand Affordable TB Treatment
MMA partner organizations in Uzbekistan, Thailand and Ukraine have filed patent oppositions against applications covering delamanid, an antibiotic used to...
-
Procurement Non-Transparency, Overreliance on Donors, and Lacking Political Will for Local Production: Recent Africa Market Intelligence Analysis
The reports, published by the Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN – Kenya), Community Health...
-
ITPC Global Hosts Summit, Marking 30 years of Global Injustice
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit brought together over 100 activists, policymakers, and researchers...
-
Brazil’s ABIA Leads Fight Against Patent Barriers to HIV, TB and Other Life-Saving Medicines
Through its Working Group on Intellectual Property (GTPI), ABIA has filed more than 40 oppositions since 2006 against patents on...
-
New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention
Lenacapavir, administered just twice a year, has been shown to reduce HIV transmission to nearly zero. However, the drug’s high...
-
A look into the findings of the Market Intelligence Study for Uganda
In full recognition of the gloom that hovers around the withdrawal of funds, allow me shed a little light to...
-
Ever-greening Patents – a Common Trick of Big Pharma, and Access to MDR TB Drug in Thailand
Chalermsak Kittitrakul, TNP+’s Project Manager for Access to Medicines, said, “The civil society’s movement on opposing the patent applications for...
-
GSIPA2M 2025 Highlights
Dive into three days of resistance, solidarity, and vision for the global fight for access to medicines. Click on the...
-
A Tribute to Courage and Justice: Honoring Professor Hakima Himmich at the GSIPA2M 2025
With emotion palpable in the air, Moroccan journalist Amine Boushaba opened the tribute by recalling his personal journey as an...
-
Marrakech to Host Critical Global Summit on Intellectual Property and Access to Medicines — TRIPS@30: The Access Crisis
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit takes place at a moment of historic urgency:...
-
An Earsplitting Silence: Pharma Makes Billions, Says Nothing About the Current Global Funding Crisis for HIV, Tuberculosis and Other Life-Threatening Illnesses
“It is shocking that the crisis facing the global HIV community has been met with such a resounding silence from...
-
‘A Matter of Life and Death’: Civil Society Groups Fight for Affordable DR-TB Treatment
“As the patent holder, Otsuka has prevented access to improved TB treatment due to its exorbitant prices. On World TB...